Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
AIM ImmunoTech Inc. (AIM) had Debt to Equity Ratio of -0.35 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.03M |
|
$-2.79M |
|
$0.01M |
|
$0.01M |
|
$2.67M |
|
$-2.65M |
|
$-0.15M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.65M |
|
$-2.19M |
|
0.76M |
|
0.76M |
|
$-3.68 |
|
$-3.68 |
|
| Balance Sheet Financials | |
$1.02M |
|
$0.09M |
|
$3.10M |
|
$4.13M |
|
$10.39M |
|
-- |
|
$0.28M |
|
$10.68M |
|
$-6.55M |
|
$-8.71M |
|
$-6.55M |
|
0.76M |
|
| Cash Flow Statement Financials | |
$-3.89M |
|
$1.65M |
|
$1.01M |
|
$1.70M |
|
$0.48M |
|
$-1.23M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-0.35 |
60.00% |
|
-10584.00% |
|
-10584.00% |
|
-- |
|
-11176.00% |
|
-11176.00% |
|
$-3.89M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
42.68% |
|
32.06% |
|
-67.67% |
|
42.68% |
|
$-8.57 |
|
$-5.13 |
|
$-5.13 |
|